CoChat

Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study

Open access

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Chronic kidney disease is an important cause of global mortality and morbidity. Data for epidemiological features of chronic kidney disease and its risk factors are limited for low-income and middle-income countries. The International Society of Nephrology's Kidney Disease Data Center (ISN-KDDC) aimed to assess the prevalence and awareness of chronic kidney disease and its risk factors, and to investigate the risk of cardiovascular disease, in countries of low and middle income. METHODS: We did a cross-sectional study in 12 countries from six world regions: Bangladesh, Bolivia, Bosnia and Herzegovina, China, Egypt, Georgia, India, Iran, Moldova, Mongolia, Nepal, and Nigeria. We analysed data from screening programmes in these countries, matching eight general and four high-risk population cohorts collected in the ISN-KDDC database. High-risk cohorts were individuals at risk of or with a diagnosis of either chronic kidney disease, hypertension, diabetes, or cardiovascular disease. Participants completed a self-report questionnaire, had their blood pressure measured, and blood and urine samples taken. We defined chronic kidney disease according to modified KDIGO (Kidney Disease: Improving Global Outcomes) criteria; risk of cardiovascular disease development was estimated with the Framingham risk score. FINDINGS: 75,058 individuals were included in the study. The prevalence of chronic kidney disease was 14·3% (95% CI 14·0-14·5) in general populations and 36·1% (34·7-37·6) in high-risk populations. Overall awareness of chronic kidney disease was low, with 409 (6%) of 6631 individuals in general populations and 150 (10%) of 1524 participants from high-risk populations aware they had chronic kidney disease. Moreover, in the general population, 5600 (44%) of 12,751 individuals with hypertension did not know they had the disorder, and 973 (31%) of 3130 people with diabetes were unaware they had that disease. The number of participants at high risk of cardiovascular disease, according to the Framingham risk score, was underestimated compared with KDIGO guidelines. For example, all individuals with chronic kidney disease should be considered at high risk of cardiovascular disease, but the Framingham risk score detects only 23% in the general population, and only 38% in high-risk cohorts. INTERPRETATION: Prevalence of chronic kidney disease was high in general and high-risk populations from countries of low and middle income. Moreover, awareness of chronic kidney disease and other non-communicable diseases was low, and a substantial number of individuals who knew they were ill did not receive treatment. Prospective programmes with repeat testing are needed to confirm the diagnosis of chronic kidney disease and its risk factors. Furthermore, in general, health-care workforces in countries of low and middle income need strengthening. FUNDING: International Society of Nephrology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2214-109x(16)00071-1

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow diagram of cohorts included in the ISN-KDDC study eGFR=estimated glomerular fi ltration rate. KDDC=Kidney Disease Data Center. KHDC=International Society of Nephrology programme on Detection and Management of Chronic Kidney Disease, Hypertension, Diabetes and Cardiovascular Disease in Developing Countries.
Figure 1 Flow diagram of cohorts included in the ISN-KDDC study eGFR=estimated glomerular fi ltration rate. KDDC=Kidney Disease Data Center. KHDC=International Society of Nephrology programme on Detection and Management of Chronic Kidney Disease, Hypertension, Diabetes and Cardiovascular Disease in Developing Countries.CC-BY-NC-ND · From the PDF
Figure 2 Prevalence of chronic kidney disease, by country Data are prevalence (95% CI).
Figure 2 Prevalence of chronic kidney disease, by country Data are prevalence (95% CI).CC-BY-NC-ND · From the PDF
Image 3
CC-BY-NC-ND · From the PDF
Image 4
CC-BY-NC-ND · From the PDF
Figure 5 Proportion of population at high risk of developing cardiovascular disease in the next 10 years by eGFR and albuminuria categories, overall and stratifi ed by sex Risk calculated according to the simpler risk prediction Framingham risk score equation based on non-laboratory predictors (sex, age, diabetes, and smoking status, treated or untreated hypertension, and body-mass index). 26 High risk defi ned as a probability greater than 20%. eGFR was calculated with the CKD-EPI equation: 21 G1, normal or high (≥90 mL/min per 1·73 m²); G2, mildly decreased (60-89 mL/min per 1·73 m²); G3a, mildly to moderately decreased (45-59 mL/min per 1·73 m²); G3b, moderately to severely decreased (30-44 mL/min per 1·73 m²); G4, severely decreased (15-29 mL/min per 1·73 m²) and G5, kidney failure (<15 mL/min per 1·73 m²). Albuminuria categories were defi ned as ACR approximate equivalent: A1, normal to mildly increased (ACR <30 mg/g); A2, moderately increased (ACR ≥30 mg/g to <300 mg/g); A3, severely increased (ACR ≥300 mg/g). ACR=albumin-to-creatinine ratio. eGFR=estimated glomerular fi ltration rate.
Figure 5 Proportion of population at high risk of developing cardiovascular disease in the next 10 years by eGFR and albuminuria categories, overall and stratifi ed by sex Risk calculated according to the simpler risk prediction Framingham risk score equation based on non-laboratory predictors (sex, age, diabetes, and smoking status, treated or untreated hypertension, and body-mass index). 26 High risk defi ned as a probability greater than 20%. eGFR was calculated with the CKD-EPI equation: 21 G1, normal or high (≥90 mL/min per 1·73 m²); G2, mildly decreased (60-89 mL/min per 1·73 m²); G3a, mildly to moderately decreased (45-59 mL/min per 1·73 m²); G3b, moderately to severely decreased (30-44 mL/min per 1·73 m²); G4, severely decreased (15-29 mL/min per 1·73 m²) and G5, kidney failure (<15 mL/min per 1·73 m²). Albuminuria categories were defi ned as ACR approximate equivalent: A1, normal to mildly increased (ACR <30 mg/g); A2, moderately increased (ACR ≥30 mg/g to <300 mg/g); A3, severely increased (ACR ≥300 mg/g). ACR=albumin-to-creatinine ratio. eGFR=estimated glomerular fi ltration rate.CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Cited by

See all 663

Metadata

Authors
Ene-Iordache, B., Perico, N., Bikbov, B., Carminati, S., Remuzzi, A., Perna, A., Islam, N., Bravo, R. F., Aleckovic-Halilovic, M., Zou, H., Zhang, L., Gouda, Z., Tchokhonelidze, I., Abraham, G., Mahdavi-Mazdeh, M., Gallieni, M., Codreanu, I., Togtokh, A., Sharma, S. K., Koirala, P., Uprety, S., Ulasi, I., & Remuzzi, G.
Affiliations
  • Mario Negri Institute for Pharmacological Research (IT)
  • Russian University of Medicine (RU)
  • University of Bergamo (IT)
  • North East Medical College (BD)
  • Third Affiliated Hospital of Southern Medical University (CN)
  • Peking University (CN)
  • General Organization For Teaching Hospitals and Institutes (EG)
  • Tbilisi State Medical University (GE)
  • University of Milan (IT)
  • B.P. Koirala Institute of Health Sciences (NP)
  • University of Nigeria (NG)
Venue
The Lancet Global Health
Publisher
Elsevier BV
Published
2016-05
Volume
4
Issue
5
Pages
e307-e319
ISSN
2214-109X (ISSN-L)
OpenAlex
W2337136207
Cited by
627
References
56
Citations by year
2026: 34 · 2025: 72 · 2024: 94 · 2023: 97 · 2022: 63 · 2021: 61 · 2020: 90 · 2019: 42 · 2018: 34 · 2017: 31 · 2016: 8
FWCI
38.56
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet Global Health (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Bushehr University of Medical Sciences Repository (Bushehr University of Medical Sciences) (acceptedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • Aisberg (University of Bergamo) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
International Society of Nephrology
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
chronic kidney disease, cardiovascular risk, prevalence, disease awareness, hypertension, diabetes mellitus, Framingham risk score, KDIGO criteria, low- and middle-income countries, cardiovascular disease, screening programs, vulnerable populations, risk underestimation, global health disparities, blood pressure, urinary biomarkers, morbidity
MeSH terms
Adult, Aged, Awareness, Bangladesh, Bolivia, Cardiovascular Diseases, China, Cross-Sectional Studies, Diabetes Mellitus, Egypt, Female, Georgia (Republic), Humans, Hypertension, India, Iran, Health Knowledge, Attitudes, Practice, Male, Mass Screening, Middle Aged, Moldova, Mongolia, Nepal, Nigeria, Surveys and Questionnaires, Risk Factors, Cohort Studies, Prevalence, Bosnia and Herzegovina, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. https://app.cochat.ai/papers/10.1016/s2214-109x(16)00071-1
The paper
Ene-Iordache, B., Perico, N., Bikbov, B., Carminati, S., Remuzzi, A., Perna, A., Islam, N., Bravo, R. F., Aleckovic-Halilovic, M., Zou, H., Zhang, L., Gouda, Z., Tchokhonelidze, I., Abraham, G., Mahdavi-Mazdeh, M., Gallieni, M., Codreanu, I., Togtokh, A., Sharma, S. K., . . . Remuzzi, G. (2016). Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(16)00071-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.